ArticleLeukemia2022

Characteristics of anti-CLL1 based CAR-T therapy for children with relapsed or refractory acute myeloid leukemia: the multi-center efficacy and safety interim analysis.

Hui Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.